New Zealand markets close in 54 minutes

Sirius XM Holdings Inc. (SIRI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6100-0.0700 (-1.90%)
At close: 04:00PM EDT
3.6200 +0.01 (+0.28%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.6800
Open3.6900
Bid3.6000 x 41800
Ask3.6200 x 1200
Day's range3.5700 - 3.6950
52-week range3.4300 - 6.8500
Volume18,371,894
Avg. volume16,794,098
Market cap14.045B
Beta (5Y monthly)0.97
PE ratio (TTM)11.65
EPS (TTM)0.3100
Earnings date26 Apr 2023 - 01 May 2023
Forward dividend & yield0.10 (2.61%)
Ex-dividend date08 Feb 2023
1y target est5.56
  • Motley Fool

    3 No-Brainer Stocks to Buy With $10 Right Now

    As much as we'd enjoy a stock market that never declined, stocks can and do move in both directions. Last year, all three major U.S. stock indexes tumbled into respective bear markets and produced their worst returns since the financial crisis. Despite 39 official stock market corrections in the benchmark S&P 500 since the beginning of 1950, all but the current decline eventually gave way to a bull market rally that took the broader market to new highs.

  • Motley Fool

    I Wouldn't Touch This Stock With a 10-Foot Pole 10 Years Ago -- Now I Can't Stop Buying Shares

    Liberty SiriusXM Group (NASDAQ: LSXMA)(NASDAQ: LSXMB)(NASDAQ: LSXMK), which is now the majority owner of Sirius XM, agreed to invest as much as $530 million in the company in February 2009. This capital provided an immediate lifeline that allowed Sirius XM to meet its debt payments and grow its business. Leading up to this ninth-inning save from Liberty, Sirius XM struggled.

  • Motley Fool

    Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?

    Now that the dust of February has settled, investors can start looking for some stocks that had an abysmal month. While the Nasdaq-100 fell 2.6% in February, a few stocks had an even worse performance. The stocks claiming this "honor" were JD.com (NASDAQ: JD), SiriusXM (NASDAQ: SIRI), and Moderna (NASDAQ: MRNA).